GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial

International Journal of Endocrinology - Tập 2019 - Trang 1-6 - 2019
Minh Tâm Lê1, Đắc Nguyên Nguyễn1, Jessica R. Zolton2, Vũ Quốc Huy Nguyễn1, Quang Vinh Truong1, Ngọc Thành Cao1, Alan H. DeCherney2, Micah J. Hill2
1Department of OBGYN, Hue University of Medicine and Pharmacy, Hue University, 06 Ngo Quyen Street, Hue, Vietnam
2Department of OBGYN, Walter Reed National Military Medical Center, Bethesda, MD, USA

Tóm tắt

This study is aimed at comparing clinical pregnancy rates (CPRs) in patients who are administered either gonadotropin-releasing hormone agonist (GnRHa) or human chorionic gonadotropin (hCG) for ovulation trigger in intrauterine insemination (IUI) cycles. A prospective randomized comparative study was conducted at Hue University Hospital in Vietnam. A total of 197 infertile women were randomly assigned to receive either GnRHa trigger (n=98 cycles) or hCG trigger (n=99 cycles) for ovulation trigger. Patients returned for ultrasound monitoring 24 hours after IUI to confirm ovulation. A clinical pregnancy was defined as the presence of gestational sac with fetal cardiac activity. There was no difference in ovulation rates in either group receiving GnRHa or hCG trigger for ovulation. Biochemical and CPR were higher in patients who received hCG (28.3% and 23.2%) versus GnRHa (14.3% and 13.3%) (p=0.023, OR 0.42, 95%CI=0.210.86 and p=0.096, OR 0.51, 95%CI=0.241.07, respectively). After adjusting for body mass index (BMI) and infertility duration, there was no difference in CPR between the two groups (OR 0.58, 95% CI 0.27-1.25, p=0.163). In conclusion, the use of the GnRHa to trigger ovulation in patients undergoing ovulation induction may be considered in patients treated with IUI.

Từ khóa


Tài liệu tham khảo

10.1093/humrep/dei475

10.1016/j.rbmo.2012.11.002

10.3109/09513598909152302

10.1080/1464727992000199811

10.1210/jcem.87.2.8197

10.1210/jcem.80.5.7744998

10.1093/molehr/5.8.726

10.1002/(SICI)1098-2795(199610)45:2<218::AID-MRD15>3.0.CO;2-X

10.1038/281483a0

10.1038/279336a0

10.1210/jcem-71-4-918

10.1016/j.fertnstert.2011.01.019

10.1210/jc.2002-021953

10.1002/14651858.CD008046.pub4

10.3389/fendo.2017.00116

10.1007/s10815-017-0982-7

10.1016/j.fertnstert.2007.02.002

10.3109/01443615.2011.569780

10.1016/j.ejogrb.2014.05.003

10.1016/j.ajog.2014.01.031

10.1093/oxfordjournals.humrep.a138750

2017, International Journal of Reproductive Biomedicine, 15, 351, 10.29252/ijrm.15.6.351

10.1210/jcem-28-12-1763

10.1016/j.fertnstert.2008.08.118

10.1016/S0015-0282(16)54474-4

10.1210/jcem-57-4-792

10.1016/j.fertnstert.2003.05.032

10.1016/j.fertnstert.2017.01.011

10.1016/j.fertnstert.2014.12.128

10.1093/humrep/deh765

10.1093/humrep/dey054

10.1186/s40064-016-2992-9